349 related articles for article (PubMed ID: 11886176)
1. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
Hu X; Cress WD; Zhong Q; Zuckerman KS
Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an E2F-p130 complex formed during growth arrest.
Corbeil HB; Branton PE
Oncogene; 1997 Aug; 15(6):657-68. PubMed ID: 9264406
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions.
Lind EF; Wayne J; Wang QZ; Staeva T; Stolzer A; Petrie HT
J Immunol; 1999 May; 162(9):5374-9. PubMed ID: 10228014
[TBL] [Abstract][Full Text] [Related]
6. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
7. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation.
Sidle A; Palaty C; Dirks P; Wiggan O; Kiess M; Gill RM; Wong AK; Hamel PA
Crit Rev Biochem Mol Biol; 1996 Jun; 31(3):237-71. PubMed ID: 8817077
[TBL] [Abstract][Full Text] [Related]
8. pRb and p107 regulate E2F activity during lens fiber cell differentiation.
Rampalli AM; Gao CY; Chauthaiwale VM; Zelenka PS
Oncogene; 1998 Jan; 16(3):399-408. PubMed ID: 9467965
[TBL] [Abstract][Full Text] [Related]
9. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex.
Le Cam L; Polanowska J; Fabbrizio E; Olivier M; Philips A; Ng Eaton E; Classon M; Geng Y; Sardet C
EMBO J; 1999 Apr; 18(7):1878-90. PubMed ID: 10202151
[TBL] [Abstract][Full Text] [Related]
10. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
O'Connor RJ; Schaley JE; Feeney G; Hearing P
Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
[TBL] [Abstract][Full Text] [Related]
11. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.
Hansen K; Farkas T; Lukas J; Holm K; Rönnstrand L; Bartek J
EMBO J; 2001 Feb; 20(3):422-32. PubMed ID: 11157749
[TBL] [Abstract][Full Text] [Related]
13. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
14. Granulocytic differentiation of myeloid progenitor cells by p130, the retinoblastoma tumor suppressor homologue.
Mori A; Higashi H; Hoshikawa Y; Imamura M; Asaka M; Hatakeyama M
Oncogene; 1999 Nov; 18(46):6209-21. PubMed ID: 10597219
[TBL] [Abstract][Full Text] [Related]
15. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
[TBL] [Abstract][Full Text] [Related]
16. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
Stiegler P; De Luca A; Bagella L; Giordano A
Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
[TBL] [Abstract][Full Text] [Related]
17. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
18. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
Wang S; Nath N; Adlam M; Chellappan S
Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
[TBL] [Abstract][Full Text] [Related]
20. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth.
Smith EJ; Leone G; Nevins JR
Cell Growth Differ; 1998 Apr; 9(4):297-303. PubMed ID: 9563849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
